M&T Bank’s Utah Medical Products UTMD Stock Holding History

M&T Bank’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-7,442	Closed	-$444K	–	2015
2015 Q2	$444K	Hold	7,442	–	–	﹤0.01%	1282
2015 Q1	$445K	Hold	7,442	–	–	﹤0.01%	1254
2014 Q4	$447K	Sell	7,442 -2,623	-26%	-$145K	﹤0.01%	1271
2014 Q3	$491K	Buy	+10,065	New	+$511K	﹤0.01%	1269

Other funds holding UTMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

MDCM

Morgan Dempsey Capital Management Menomonee Falls, Wisconsin $220M AUM 18.32% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

M&T Bank's UTMD Position: Q3 2015 in Review

M&T Bank sold out of Utah Medical Products (UTMD) in Q3 2015, closing a stake of 7,442 shares — an estimated $444K sold.

M&T Bank first reported a position in UTMD in Q3 2014 and held it in 4 quarters. The position peaked at $491K in Q3 2014. 59 funds tracked by Wall St. Rank hold UTMD as of Q3 2015.

M&T Bank reported no remaining Utah Medical Products position as of Q3 2015 after selling out during the quarter.
M&T Bank sold 7,442 Utah Medical Products shares in Q3 2015, an estimated $444K.
M&T Bank first reported a position in Utah Medical Products in Q3 2014 and held it in 4 quarters.
M&T Bank's Utah Medical Products position peaked at $491K in Q3 2014.
59 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2015.

Based on M&T Bank's 13F filing for Q3 2015, filed 13 Nov 2015.